A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

The study could not account for other mediators of cardiovascular risk and breastfeeding, such as social determinants of ...

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 ...

Discover how modern diabetes medications offer cardiovascular benefits, transforming diabetes care and improving outcomes worldwide.

Many treatments exist to minimize the effects of cardiovascular disease on quality of life and longevity but, an ounce of ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...